Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Sanderson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Medicinal Research Reviews|April 3, 1999
Small, noncovalent serine protease inhibitorsP E Sanderson
Coronary Artery Disease|July 1, 1998
Novel anticoagulants based on direct inhibition of thrombin and factor XaS J Gardell, P E Sanderson
Current Medicinal Chemistry|July 21, 1998
Thrombin inhibitor designP E Sanderson, A M Naylor-Olsen
Chemico-Biological Interactions|July 29, 1998
Glutathione based approaches to improving cancer treatmentL M Kauvar, A S Morgan, P E Sanderson, et al.
Anti-Cancer Drugs|April 1, 1997
Activity of TER286 against human tumor colony-forming unitsE Izbicka, R Lawrence, C Cerna, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Correlation of anti-emetic efficacy and plasma levels of ondansetronS M Grunberg, S Groshen, D C Robinson, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Ondansetron is effective in decreasing postoperative nausea and vomitingM Dershwitz, C E Rosow, P M Di Biase, et al.
Anesthesiology|September 1, 1992
Ondansetron does not affect alfentanil-induced ventilatory depression or sedationM Dershwitz, P M Di Biase, C E Rosow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesisS M Grunberg, M Lane, E P Lester, et al.
The Journal of Biological Chemistry|March 28, 1998
Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogsS D Lewis, B J Lucas, S F Brady, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Medicinal Research Reviews|April 3, 1999
Small, noncovalent serine protease inhibitorsP E Sanderson
Coronary Artery Disease|July 1, 1998
Novel anticoagulants based on direct inhibition of thrombin and factor XaS J Gardell, P E Sanderson
Current Medicinal Chemistry|July 21, 1998
Thrombin inhibitor designP E Sanderson, A M Naylor-Olsen
Chemico-Biological Interactions|July 29, 1998
Glutathione based approaches to improving cancer treatmentL M Kauvar, A S Morgan, P E Sanderson, et al.
Anti-Cancer Drugs|April 1, 1997
Activity of TER286 against human tumor colony-forming unitsE Izbicka, R Lawrence, C Cerna, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Correlation of anti-emetic efficacy and plasma levels of ondansetronS M Grunberg, S Groshen, D C Robinson, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Ondansetron is effective in decreasing postoperative nausea and vomitingM Dershwitz, C E Rosow, P M Di Biase, et al.
Anesthesiology|September 1, 1992
Ondansetron does not affect alfentanil-induced ventilatory depression or sedationM Dershwitz, P M Di Biase, C E Rosow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesisS M Grunberg, M Lane, E P Lester, et al.
The Journal of Biological Chemistry|March 28, 1998
Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogsS D Lewis, B J Lucas, S F Brady, et al.
Pageof 2